Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 155

1.

A critical role of IL-17 in modulating the B-cell response during H5N1 influenza virus infection.

Wang X, Chan CC, Yang M, Deng J, Poon VK, Leung VH, Ko KH, Zhou J, Yuen KY, Zheng BJ, Lu L.

Cell Mol Immunol. 2011 Nov;8(6):462-8. doi: 10.1038/cmi.2011.38. Epub 2011 Sep 26.

2.

Highly pathogenic avian influenza A H5N1 and pandemic H1N1 virus infections have different phenotypes in Toll-like receptor 3 knockout mice.

Leung YH, Nicholls JM, Ho CK, Sia SF, Mok CK, Valkenburg SA, Cheung P, Hui KP, Chan RW, Guan Y, Akira S, Peiris JS.

J Gen Virol. 2014 Sep;95(Pt 9):1870-9. doi: 10.1099/vir.0.066258-0. Epub 2014 May 30.

3.

Caspase-1 deficient mice are more susceptible to influenza A virus infection with PA variation.

Huang CH, Chen CJ, Yen CT, Yu CP, Huang PN, Kuo RL, Lin SJ, Chang CK, Shih SR.

J Infect Dis. 2013 Dec 1;208(11):1898-905. doi: 10.1093/infdis/jit381. Epub 2013 Jul 30.

PMID:
23901080
4.

Parasite-mediated upregulation of NK cell-derived gamma interferon protects against severe highly pathogenic H5N1 influenza virus infection.

O'Brien KB, Schultz-Cherry S, Knoll LJ.

J Virol. 2011 Sep;85(17):8680-8. doi: 10.1128/JVI.05142-11. Epub 2011 Jul 6.

5.

Role of host cytokine responses in the pathogenesis of avian H5N1 influenza viruses in mice.

Szretter KJ, Gangappa S, Lu X, Smith C, Shieh WJ, Zaki SR, Sambhara S, Tumpey TM, Katz JM.

J Virol. 2007 Mar;81(6):2736-44. Epub 2006 Dec 20.

6.

Use of praziquantel as an adjuvant enhances protection and Tc-17 responses to killed H5N1 virus vaccine in mice.

Zou Q, Hu Y, Xue J, Fan X, Jin Y, Shi X, Meng D, Wang X, Feng C, Xie X, Zhang Y, Kang Y, Liang X, Wu B, Wang M, Wang B.

PLoS One. 2012;7(4):e34865. doi: 10.1371/journal.pone.0034865. Epub 2012 Apr 18.

7.

Inducible nitric oxide contributes to viral pathogenesis following highly pathogenic influenza virus infection in mice.

Perrone LA, Belser JA, Wadford DA, Katz JM, Tumpey TM.

J Infect Dis. 2013 May 15;207(10):1576-84. doi: 10.1093/infdis/jit062. Epub 2013 Feb 18.

PMID:
23420903
8.

Spin90 deficiency increases CXCL13-mediated B cell migration.

Park SH, Kim HR, Jun CD, Song WK, Park SG.

Scand J Immunol. 2014 Sep;80(3):191-7. doi: 10.1111/sji.12203.

9.

Autophagy mediates avian influenza H5N1 pseudotyped particle-induced lung inflammation through NF-κB and p38 MAPK signaling pathways.

Pan H, Zhang Y, Luo Z, Li P, Liu L, Wang C, Wang H, Li H, Ma Y.

Am J Physiol Lung Cell Mol Physiol. 2014 Jan;306(2):L183-95. doi: 10.1152/ajplung.00147.2013. Epub 2013 Nov 15.

10.
12.

CD8+ Treg cells suppress CD8+ T cell-responses by IL-10-dependent mechanism during H5N1 influenza virus infection.

Zou Q, Wu B, Xue J, Fan X, Feng C, Geng S, Wang M, Wang B.

Eur J Immunol. 2014 Jan;44(1):103-14. doi: 10.1002/eji.201343583. Epub 2013 Nov 4.

13.

Kinetic characterization of PB1-F2-mediated immunopathology during highly pathogenic avian H5N1 influenza virus infection.

Leymarie O, Jouvion G, Hervé PL, Chevalier C, Lorin V, Lecardonnel J, Da Costa B, Delmas B, Escriou N, Le Goffic R.

PLoS One. 2013;8(3):e57894. doi: 10.1371/journal.pone.0057894. Epub 2013 Mar 1.

14.

H5N1 and 1918 pandemic influenza virus infection results in early and excessive infiltration of macrophages and neutrophils in the lungs of mice.

Perrone LA, Plowden JK, García-Sastre A, Katz JM, Tumpey TM.

PLoS Pathog. 2008 Aug 1;4(8):e1000115. doi: 10.1371/journal.ppat.1000115.

15.

Efficacy of inactivated vaccine against H5N1 influenza virus infection in mice with type 1 diabetes.

Wu J, Zhang F, Fang F, Chang H, Wang F, Yang Z, Sun B, Chen Z.

Vaccine. 2010 Mar 24;28(15):2775-81. doi: 10.1016/j.vaccine.2010.01.037. Epub 2010 Jan 29.

PMID:
20117261
16.

Lethal dissemination of H5N1 influenza virus is associated with dysregulation of inflammation and lipoxin signaling in a mouse model of infection.

Cilloniz C, Pantin-Jackwood MJ, Ni C, Goodman AG, Peng X, Proll SC, Carter VS, Rosenzweig ER, Szretter KJ, Katz JM, Korth MJ, Swayne DE, Tumpey TM, Katze MG.

J Virol. 2010 Aug;84(15):7613-24. doi: 10.1128/JVI.00553-10. Epub 2010 May 26.

17.

Vaccination against human influenza A/H3N2 virus prevents the induction of heterosubtypic immunity against lethal infection with avian influenza A/H5N1 virus.

Bodewes R, Kreijtz JH, Baas C, Geelhoed-Mieras MM, de Mutsert G, van Amerongen G, van den Brand JM, Fouchier RA, Osterhaus AD, Rimmelzwaan GF.

PLoS One. 2009;4(5):e5538. doi: 10.1371/journal.pone.0005538. Epub 2009 May 14.

18.

IL-21R signaling suppresses IL-17+ gamma delta T cell responses and production of IL-17 related cytokines in the lung at steady state and after Influenza A virus infection.

Moser EK, Sun J, Kim TS, Braciale TJ.

PLoS One. 2015 Apr 7;10(4):e0120169. doi: 10.1371/journal.pone.0120169. eCollection 2015.

19.

Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.

Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, Guo F, Bai T, Han Z, Zhu J, Zhou H, Huang F, Li C, Lu H, Li N, Li D, Jin N, Penninger JM, Jiang C.

Nat Commun. 2014 May 6;5:3594. doi: 10.1038/ncomms4594.

PMID:
24800825
20.

Gene expression analysis of host innate immune responses during Lethal H5N1 infection in ferrets.

Cameron CM, Cameron MJ, Bermejo-Martin JF, Ran L, Xu L, Turner PV, Ran R, Danesh A, Fang Y, Chan PK, Mytle N, Sullivan TJ, Collins TL, Johnson MG, Medina JC, Rowe T, Kelvin DJ.

J Virol. 2008 Nov;82(22):11308-17. doi: 10.1128/JVI.00691-08. Epub 2008 Aug 6.

Supplemental Content

Support Center